42 Results

People

  1. Downs-Canner
    Downs-Canner
  2. Palomba
    Palomba
  3. Abuhadra
    Abuhadra
  4. Mato
    Mato
  5. Morrow
    Morrow
  6. Plitas
    Plitas
  7. Sevilimedu Veeravalli
    Sevilimedu Veeravalli
  8. Thompson
    Thompson
  9. Arbour
    Arbour
  10. Bott
    Bott

Groups

  1. Department of Medicine (26)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (15)
  4. Solid Tumor Oncology Division (10)
  5. Surgery (10)
  6. Graduate Medical Education (9)
  7. Lymphoma (8)
  8. GME, Medicine (6)
  9. Hematology-Oncology Fellows (6)
  10. Thoracic Oncology (6)
  1. "chemoimmunotherapy"
Formats
  1. Journal Article (23)
  2. Review (6)
  3. Editorial (5)
  4. Correspondence (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Meeting Abstract (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (26)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (15)
  4. Solid Tumor Oncology Division (10)
  5. Surgery (10)
  6. Graduate Medical Education (9)

More Groups

People
  1. Anthony Mato (4)
  2. Lindsey Roeker (4)
  3. Maria Palomba (4)
  4. Stephanie Downs-Canner (4)
  5. George Plitas (3)
  6. Meghan Thompson (3)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (6)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Annals of Surgical Oncology (4)
  2. Journal of Thoracic and Cardiovascular Surgery (3)
  3. Annals of Oncology (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (2)
  5. European Journal of Cancer (2)
  6. Haematologica (2)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Springer (5)
  3. Lippincott Williams & Wilkins (3)
  4. Mosby Elsevier (3)
  5. Nature Publishing Group (3)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Journal Article

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - A US multisite study
    Correspondence

    Epperla, N.; Shouse, G.; Grover, N. S.; Torka, P.; Annunzio, K.; Watkins, M.; Anampa-Guzmán, A.; Christian, B.; Thomas, C.; Barta, S. K.; more...
    Experimental Hematology and Oncology (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Miscellaneous

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
    Research Letter

    Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL
    Review

    Soumerai, J. D.; Barrientos, J.; Ahn, I.; Coombs, C.; Gladstone, D.; Hoffman, M.; Kittai, A.; Jacobs, R.; Lipsky, A.; Patel, K.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
    Journal Article

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Commentary: Cracking the code: Deciphering predictors of treatment response in non–small cell lung cancer
    Editorial

    Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • Help or hindrance? Rituximab maintenance and COVID
    Editorial

    Noy, A.
    Haematologica (2025)

    Fulltext@MSK | Save
  • Real world characteristics and distant metastasis free survival of patients with early NSCLC treated with chemoimmunotherapy
    Meeting Abstract

    Schwed, K.; Kalesinskas, L.; Yuan, Q.; Keane, C. A.; Fidyk, E. L.; Castellanos, E.; Cohen, A. B.; Harrison, K.; Ho, G.; Marinescu, A.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save